NEW YORK, August 11, 2015 /PRNewswire/ --
Equity Research Institute has initiated coverage on the
following equities: Garmin Ltd (NASDAQ: GRMN), Keysight
Technologies Inc. (NYSE: KEYS), Transgenomic Inc. (NASDAQ: TBIO),
Affymetrix Inc. (NASDAQ: AFFX), and FLIR Systems Inc. (NASDAQ:
FLIR). Free research report on Garmin can be accessed at
https://www.EquityResearchInstitute.com/reports?keyword=GRMN On
Monday, August 10, 2015, the NASDAQ
Composite ended at 5,101.80, up 1.15%, the Dow Jones Industrial
Average advanced 1.39%, to finish the day at 17,615.17, and the
S&P 500 closed at 2,104.18, up 1.28%. The gains were broad
based as all the sectors ended the session in positive. Register
for your complimentary reports at the links given below.
Garmin Ltd's stock finished Monday's session 1.13% higher at
$41.08. A total of 1.20 million
shares were traded, which was below its three months average volume
of 1.44 million shares. Over the last one month and the previous
three months, Garmin Ltd's shares have declined 7.00% and 11.09%,
respectively. Additionally, the stock has lost 21.37% since the
beginning of 2015. The company's shares are trading below their
50-day and 200-day moving averages by 6.90% and 16.00%,
respectively. Garmin Ltd's stock traded at a PE ratio of 29.34 and
has a Relative Strength Index (RSI) of 37.13. Sign up and read the
free notes on GRMN at:
https://www.EquityResearchInstitute.com/reports?keyword=GRMN
On Monday, shares in Keysight Technologies Inc. ended the
session 2.61% higher at $30.64. The
stock reported a trading volume of 0.46 million shares, below its
three months average volume of 0.92 million shares. Shares of the
company traded at a PE ratio of 13.80. Although, Keysight
Technologies Inc.'s shares have advanced 0.96% in the last one
month, it has lost 12.51% in the previous three months and 9.27% on
YTD basis. The company is trading 2.89% below its 50-day moving
average and 9.28% below its 200-day moving average. Moreover,
shares of Keysight Technologies Inc. have an RSI of 48.71. The
complimentary notes on KEYS can be downloaded in PDF format at:
https://www.EquityResearchInstitute.com/reports?keyword=KEYS
Transgenomic Inc.'s stock edged 0.01% higher, to close the day
at $1.24. The stock recorded a
trading volume of 0.08 million shares, much below its three months
average volume of 0.89 million shares. Over the last one month and
over the past three months, Transgenomic Inc.'s shares have
declined 9.48% and 19.47%, respectively. Furthermore, the stock has
lost 38.30% since the start of this year. The company's shares are
trading 28.90% below their 50-day moving average. Additionally,
Transgenomic Inc. has an RSI of 27.97. Register for free on Equity
Research Institute and access the latest research on TBIO at:
https://www.EquityResearchInstitute.com/reports?keyword=TBIO
On Monday, shares in Affymetrix Inc. recorded a trading volume
of 0.83 million shares, higher than their three months average
volume of 0.75 million shares. The stock ended the day 1.19% higher
at $10.24. Shares of the company
traded at a PE ratio of 42.67. Affymetrix Inc.'s stock has lost
7.33% in the last one month and 16.95% in the previous three
months. However, the stock has advanced 3.75% on YTD basis. The
company is trading below its 50-day and 200-day moving averages by
8.75% and 7.50%, respectively. Furthermore, shares of Affymetrix
Inc. have an RSI of 33.53. The complete research on AFFX is
available for free at:
https://www.EquityResearchInstitute.com/reports?keyword=AFFX
FLIR Systems Inc.'s stock gained 2.96%, to close Monday's
session at $31.99. The stock recorded
a trading volume of 0.88 million shares, above its three months
average volume of 0.62 million shares. Over the last one month and
the previous three months, FLIR Systems Inc.'s shares have advanced
4.65% and 1.81%, respectively. However, the stock has lost 0.31%
since the start of this year. The company is trading 3.96% and
2.07% above its 50-day and 200-day moving averages, respectively.
Furthermore, FLIR Systems Inc.'s stock traded at a PE ratio of
20.38 and has an RSI of 65.98. Free in-depth research on FLIR is
available at:
https://www.EquityResearchInstitute.com/reports?keyword=FLIR
--
About Equity Research Institute:
Equity Research Institute ("ERI") produces regular sponsored and
non-sponsored reports, articles, stock market blogs, and popular
investment newsletters covering equities listed on NYSE and NASDAQ
and micro-cap stocks. ERI has two distinct and independent
departments. One department produces non-sponsored analyst
certified content generally in the form of press releases, articles
and reports covering equities listed on NYSE and NASDAQ and the
other produces sponsored content (in most cases not reviewed by a
registered analyst), which typically consists of compensated
investment newsletters, articles and reports covering listed stocks
and micro-caps. Such sponsored content is outside the scope of
procedures detailed below.
ERI has not been compensated; directly or indirectly; for
producing or publishing this document.
PRESS RELEASE PROCEDURES:
The non-sponsored content contained herein has been prepared by
a writer (the "Author") and is fact checked and reviewed by a third
party research service company (the "Reviewer"). Rohit Tuli, a CFA® charter holder (the "CFA®"),
provides necessary guidance in preparing the document templates.
The Reviewer has reviewed and revised the content, as necessary,
based on sound investment judgment and publicly available
information which is believed to be reliable. The Reviewer and the
CFA® have not performed any independent investigations or forensic
audits to validate the information herein. Unless otherwise noted,
any content outside of this document has no association with the
Author, the Reviewer, or the CFA® (collectively referred to as the
"Production Team") in any way. The Production Team is compensated
on a fixed monthly basis and do not hold any positions of interest
in any of the securities mentioned herein.
NO WARRANTY
ERI, the Author, the Reviewer and the CFA® (collectively
referred to as the "Publishers") are not responsible for any error
which may be occasioned at the time of printing of this document or
any error, mistake or shortcoming. No liability is accepted by the
Publishers whatsoever for any direct, indirect or consequential
loss arising from the use of this document. The Publishers
expressly disclaim any fiduciary responsibility or liability for
any consequences, financial or otherwise arising from any reliance
placed on the information in this document. Additionally, the
Publishers do not (1) guarantee the accuracy, timeliness,
completeness or correct sequencing of the information, or (2)
warrant any results from use of the information. The included
information is subject to change without notice.
NOT AN OFFERING
This document is not intended as an offering, recommendation, or
a solicitation of an offer to buy or sell the securities mentioned
or discussed, and is to be used for informational purposes only.
Please read all associated disclosures and disclaimers in full
before investing. Neither ERI nor any party affiliated with us is a
registered investment adviser or broker-dealer with any agency or
in any jurisdiction whatsoever. To download our report(s), read our
disclosures, or for more information, visit
http://www.equityresearchinstitute.com.
RESTRICTIONS
ERI is not available to residents of Belarus, Cuba, Canada,
Iran, North Korea, Sudan, Syria
or Somalia. Do not send email to
robottrap (at) equityresearchinstitute.com.
CFA® and Chartered Financial Analyst® are registered trademarks
owned by CFA Institute.
SOURCE www.equityresearchinstitute.com